Rubix LS Announces New Evidence-to-Product Initiatives in Collaboration with TheraSyn Bio
Rubix LS Announces New Evidence-to-Product Initiatives in Collaboration with TheraSyn Bio Building from the direction established through Project Panacea, Rubix LS will own and lead new evidence assets in chronic…